Table 2.
The association between individual benzodiazepine use and dementia based on the FAERS database.
Cases | Non-cases | ROR | 95% CI | IC | 95% CI | |
---|---|---|---|---|---|---|
Benzodiazepines | 50,302 | 1,001,070 | 1.63 | 1.61-1.64 | 0.66 | 0.65-0.67 |
Short-acting | 800 | 18,637 | 1.38 | 1.28-1.48 | 0.44 | 0.34-0.55 |
Etizolam | 691 | 16,019 | 1.38 | 1.28-1.49 | 0.45 | 0.34-0.56 |
Clotiazepam | 107 | 2,597 | 1.32 | 1.09-1.60 | 0.38 | 0.10-0.67 |
Flutazolam | 2 | 21 | 3.05 | 0.72-13.01 | 0.80 | -0.97-2.56 |
Medium-acting | 35,772 | 739,016 | 1.56 | 1.54-1.58 | 0.61 | 0.59-0.62 |
Lorazepam | 16,245 | 327959 | 1.59 | 1.57-1.62 | 0.64 | 0.62-0.66 |
Alprazolam | 18,075 | 384,519 | 1.51 | 1.49-1.53 | 0.57 | 0.55-0.59 |
Fludiazepam | 3 | 279 | 0.34 | 0.11-1.07 | -1.26 | -2.71-0.20 |
Bromazepam | 1,444 | 26,161 | 1.77 | 1.68-1.87 | 0.79 | 0.71-0.87 |
Nimetazepam | 5 | 98 | 1.63 | 0.67-4.02 | 0.53 | -0.68-1.74 |
Long-acting | 13,186 | 233,750 | 1.81 | 1.78-1.85 | 0.82 | 0.79-0.84 |
Diazepam | 11,267 | 195,417 | 1.85 | 1.82-1.89 | 0.85 | 0.82-0.88 |
Cloxazolam | 200 | 3,084 | 2.08 | 1.80-2.40 | 1.00 | 0.79-1.21 |
Chlordiazepoxide | 740 | 17,880 | 1.33 | 1.23-1.43 | 0.39 | 0.28-0.50 |
Medazepam | 15 | 220 | 2.18 | 1.29-3.69 | 0.97 | 0.23-1.72 |
Clorazepate | 964 | 17,149 | 1.80 | 1.69-1.92 | 0.81 | 0.72-0.91 |
Ultra-long-acting | 544 | 9,667 | 1.80 | 1.65-1.97 | 0.81 | 0.69-0.94 |
Flutoprazepam | 6 | 161 | 1.19 | 0.53-2.70 | 0.20 | -0.91-1.32 |
Loflazepate | 185 | 3,483 | 1.70 | 1.47-1.97 | 0.73 | 0.51-0.95 |
Mexazolam | 7 | 182 | 1.23 | 0.58-2.62 | 0.24 | -0.80-1.29 |
Oxazolam | 18 | 294 | 1.96 | 1.22-3.16 | 0.86 | 0.18-1.54 |
Cases: number of reports of dementia
Non-cases: all reports of adverse drug reactions other than dementia
ROR: reporting odds ratio
IC: information component
CI: confidence interval